Eli Lilly Gets FDA Expanded Indication For Type 2 Diabetes Treatment Synjardy To Add Treatment-Naïve Adults
July 19, 2016 at 09:11 AM EDT
Eli Lilly and Company (NYSE: LLY) disclosed that the FDA has approved an expanded indication for Synjardy (empagliflozin and ...